Newsfeeds - Spark Newswire

2 minute read

News

SOPHiA GENETICS And QIAGEN Forge Partnership To Combine Strengths In Next-generation Sequencing

Today, 8:32 PM

SOPHiA GENETICS (NASDAQ:SOPH), a cloud-native software company in the healthcare space, today announced a new partnership with QIAGEN N.V. (NYSE:QGEN) that will pair QIAseq reagent technology with the SOPHiA

QGEN

1 minute read

BTIG Initiates Coverage On Sophia Genetics with Buy Rating, Announces Price Target of $6

By Benzinga Newsdesk

Today, 8:32 PM

BTIG analyst Mark Massaro initiates coverage on Sophia Genetics (NASDAQ:SOPH) with a Buy rating and announces Price Target of $6.

SOPH

1 minute read

Credit Suisse Initiates Coverage On Sophia Genetics with Neutral Rating, Announces Price Target of $2

By Benzinga Newsdesk

Today, 8:32 PM

Credit Suisse analyst Phil Winslow initiates coverage on Sophia Genetics (NASDAQ:SOPH) with a Neutral rating and announces Price Target of $2.

SOPH

16 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 8:32 PM

On Wednesday, 283 companies set new 52-week lows.

ACHL

21 minute read

Earnings

Earnings Scheduled For November 8, 2022

By Benzinga Insights

Today, 8:32 PM

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.

ABCL

2 minute read

News

‘SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis’ – SEC

By Benzinga Newsdesk

Today, 8:32 PM

https://www.sec.gov/Archives/edgar/data/1840706/000095010322018818/dp183563_ex9901.htm The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDMTM health data analysis platform available

AMZN

25 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 8:32 PM

On Friday morning, 446 companies hit new 52-week lows.

ABG

1 minute read

Morgan Stanley Maintains Overweight on Sophia Genetics, Lowers Price Target to $13

By Benzinga Newsdesk

Today, 8:32 PM

Morgan Stanley analyst Tejas Savant maintains Sophia Genetics (NASDAQ:SOPH) with a Overweight and lowers the price target from $14 to $13.

SOPH

22 minute read

Earnings Scheduled For August 9, 2022

By Benzinga Insights

Today, 8:32 PM

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

AAIC

3 minute read

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 8:32 PM

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

AGRX